Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248872 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients
A NA study of Hypertension, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 278
- Enrollment target
- 1
- Study location
NCT00248872: Completed NA study of Hypertension, sponsored by Weill Medical College of Cornell University.
NCT00248872 is a NA study of Hypertension that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 278 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00248872, a NA study of Hypertension, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 278 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-related outcomes such as end-stage renal disease, stroke, and cardiovascular mortality among African American patients with poorly controlled hypertension.
Conditions Studied
Interventions
- BEHAVIORAL Intervention Group
Study Locations (1)
New York
- The New York Presbyterian Hospital-Weill Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00248872 record still lists
NCT00248872 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group is the first listed.
NCT00248872 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00248872 about?
NCT00248872 is a clinical study titled "A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients". The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-related outcomes such as end-stage renal disease, stroke, and cardiovascular mortality among African ...
What is the current status of trial NCT00248872?
This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2004-10. Estimated completion is 2008-07.
What conditions does trial NCT00248872 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT00248872?
The interventions under investigation include: Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00248872?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00248872 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00248872's enrollment target sits among peer trials
278 186th of 470 higher than 284 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia